Page 2 - Andreab Troxel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

No association with clinical outcomes for typical patients; heterogeneity of treatment effect sizes seen across baseline characteristics.

For the typical patient, COVID-19 convalescent plasma (CCP) is not associated with clinical outcomes.

Transfusions of blood plasma donated by people who have recovered from COVID-19 may help patients hospitalized with the virus, a new international study shows.

ALEX EDELMAN/AFP via Getty Images(NEW YORK) -- Medical researchers say there is renewed promise in reducing COVID-19-related hospitalizations and deaths by increasing the use of convalescent plasma treatments early on in a coronavirus infection. And some medical experts are pushing the federal government to allow more patients to receive the treatment, as lab-based monoclonal treatments such as Regeneron have seen lessened effectiveness against the omicron variant. Researchers at John Hopkins University on Tuesday released the results of a 16-month nationwide study on convalescent plasma use o...

A new study found using plasma from COVID-19 survivors early in an infection period prevents hospitalization.